GlassScriptPhysician profile
Kenneth P Martinez
NPI 1093825259
$336,151.13
in general payments reported to CMS, 2019-2025
89 companies · $71K in 2025
The $71K reported for 2025 was more than what 97% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $32K · 2021: $55K · 2022: $63K · 2023: $58K · 2024: $41K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $83K · Consulting Fee: $53K · Food and Beverage: $26K · Travel and Lodging: $8,114 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $83,390.00 |
| Consulting Fee | $53,134.50 |
| Food and Beverage | $25,637.99 |
| Travel and Lodging | $8,113.70 |
| Education | $109.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $119,468.76 | 2019-2025 | |
| Merz Pharmaceuticals, LLC | $95,062.47 | 2021-2025 | Xeomin, Inbrija |
| Allergan, INC. | $43,710.84 | 2019-2022 | |
| Amgen INC. | $17,614.86 | 2019-2025 | Aimovig, Uplizna |
| Biohaven Pharmaceuticals, INC. | $8,309.08 | 2020-2021 | |
| Boston Scientific Corporation | $4,710.35 | 2019-2025 | General - Therapies, General - Dbs |
| Merz North America, INC. | $4,182.04 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $4,033.54 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbott Laboratories | $3,096.52 | 2020-2025 | Infinity |
| Biohaven Pharmaceutical Holding Company LTD. | $2,936.00 | 2022 | |
| Janssen Global Services, LLC | $2,861.25 | 2023 | |
| Neurocrine Biosciences, INC. | $2,835.02 | 2019-2025 | Ingrezza, Ongentys |
| Medtronic, INC. | $2,361.74 | 2021-2025 | Percept PC Brainsense, Activa PC |
| Ucb, INC. | $2,189.07 | 2019-2025 | Rystiggo, Nayzilam, Briviact |
| Alexion Pharmaceuticals, INC. | $1,849.05 | 2019-2025 | Ultomiris, Soliris |
Show all 89 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $1,522.42 | 2020-2025 | Xcopri |
| Lilly USA, LLC | $1,234.92 | 2019-2025 | Emgality, Kisunla, Amyvid |
| Jazz Pharmaceuticals INC. | $1,024.17 | 2019-2025 | |
| Pfizer INC. | $901.95 | 2022-2025 | |
| Kyowa Kirin, INC. | $875.99 | 2019-2024 | Nourianz |
| Amneal Pharmaceuticals LLC | $835.91 | 2019-2025 | Rytary, Crexont |
| Csl Behring | $834.89 | 2019-2025 | Hizentra |
| Lundbeck LLC | $831.26 | 2019-2025 | Vyepti, Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $800.94 | 2019-2025 | Hyqvia, Gammagard |
| Eisai INC. | $785.52 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $643.26 | 2019-2025 | Nuplazid |
| Mdd US Operations, LLC | $605.59 | 2019-2025 | Gocovri, Gocovri, Qelbree |
| Upsher-Smith Laboratories LLC | $585.69 | 2019-2023 | |
| Argenx US, INC. | $578.95 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Adamas Pharmaceuticals, INC. | $530.99 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $407.16 | 2019-2022 | |
| Biogen, INC. | $397.92 | 2019-2025 | Leqembi, Spinraza, Qalsody |
| Acorda Therapeutics, INC | $370.64 | 2019-2024 | Inbrija |
| Sunovion Pharmaceuticals INC. | $343.21 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $336.09 | 2020-2022 | |
| Neuropace, INC. | $327.83 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $316.20 | 2023-2025 | Dysport |
| Neurelis, INC. | $301.95 | 2020-2025 | Valtoco |
| Avadel Cns Pharmaceuticals, LLC | $275.68 | 2024-2025 | Lumryz |
| Alnylam Pharmaceuticals INC. | $268.03 | 2021-2024 | Amvuttra, Onpattro |
| Axsome Therapeutics, INC. | $227.95 | 2023-2025 | Sunosi, Symbravo, Auvelity |
| Revance Therapeutics, INC. | $227.54 | 2024 | Daxi, Daxxify |
| Avion Pharmaceuticals | $226.11 | 2022-2023 | Dhivy |
| Tanabe Pharma America, INC. | $223.75 | 2020-2025 | Radicava |
| Ge Healthcare | $222.91 | 2019-2024 | |
| Otsuka America Pharmaceutical, INC. | $217.43 | 2023-2025 | Rexulti, Nuedexta |
| Harmony Biosciences LLC | $213.70 | 2020-2025 | |
| Nevro Corp. | $208.18 | 2020-2024 | Senza |
| Scilex Pharmaceuticals INC. | $182.54 | 2019-2024 | Ztlido |
| Catalyst Pharmaceuticals, INC. | $181.77 | 2021-2025 | Fycompa |
| Medtronic USA, INC. | $180.32 | 2019 | |
| Azurity Pharmaceuticals, INC. | $156.38 | 2023-2025 | Horizant, Horizant |
| Janssen Biotech, INC. | $156.32 | 2025 | |
| Averitas Pharma INC. | $152.20 | 2024-2025 | Qutenza |
| Corium, LLC | $147.53 | 2022-2023 | Adlarity |
| Novartis Pharmaceuticals Corporation | $141.25 | 2019-2020 | |
| Insightec,INC | $134.65 | 2022-2024 | Exablate |
| Microtransponder, INC. | $131.53 | 2023 | |
| Arbor Pharmaceuticals, INC. | $112.60 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $100.70 | 2024-2025 | |
| Livanova USA, INC. | $99.10 | 2020-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Akcea Therapeutics, INC. | $96.33 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $90.92 | 2020-2025 | Onzetra Xsail |
| Greenwich Biosciences, INC. | $83.48 | 2019 | |
| Vertical Pharmaceuticals, LLC | $81.66 | 2019 | |
| Zyla Life Sciences, INC. | $80.87 | 2019-2020 | |
| Forte Bio-Pharma LLC | $73.68 | 2025 | Tanlor |
| Genentech USA, INC. | $71.84 | 2022 | |
| Bausch Health US, LLC | $71.49 | 2019 | |
| Assertio Therapeutics, INC. | $69.55 | 2019-2020 | |
| Alfasigma USA, INC. | $66.26 | 2020-2022 | |
| Curonix LLC | $64.39 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Grifols USA, LLC | $60.48 | 2023-2024 | Gamunex-C |
| Strongbridge US INC. | $59.41 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $49.48 | 2021-2023 | Keveyis |
| Octapharma USA, INC. | $44.31 | 2023 | Panzyga |
| Horizon Therapeutics Plc | $37.07 | 2022 | |
| Merck Sharp & Dohme LLC | $25.75 | 2022 | |
| Cala Health, INC. | $24.26 | 2022 | |
| Almatica Pharma LLC | $24.10 | 2021 | |
| Promius Pharma LLC | $23.89 | 2019 | |
| Amylyx Pharmaceuticals, INC. | $22.55 | 2023 | Relyvrio |
| Impel Pharmaceuticals LLC | $21.55 | 2024 | Trudhesa |
| Portola Pharmaceuticals, LLC | $20.32 | 2019 | |
| W. L. Gore & Associates, INC. | $18.87 | 2020 | |
| Sun Pharmaceutical Industries INC. | $18.29 | 2021 | |
| Owp Pharmaceuticals, INC. | $17.24 | 2022 | |
| Sonex Health, INC. | $15.67 | 2020 | |
| Tonix Medicines, INC. | $15.21 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.